Viewing Study NCT00002903


Ignite Creation Date: 2025-12-24 @ 7:23 PM
Ignite Modification Date: 2025-12-26 @ 8:28 AM
Study NCT ID: NCT00002903
Status: COMPLETED
Last Update Posted: 2012-07-02
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module